HARTFORD — The chief of Connecticut’s medical marijuana program said Wednesday he will draft regulations to allow the drug to be used by those who suffer from complex regional pain syndrome, immediately following a unanimous recommendation by a physician review board.
Consumer Protection Commissioner Jonathan A. Harris, who oversees the medical marijuana program, added the medical condition — marked by severe pain, swelling and hypersensitivity to touch following an injury or surgery — to the list of medical conditions approved for medical marijuana.
In a 4-0 vote Wednesday, the state’s Medical Marijuana Program Board of Physicians recommended the syndrome be added to the list of conditions, noting that it was in the same vein as other neuropathic pain — pain that accompanies damage to nerve fibers causing them to misfire — already covered by medical marijuana laws.
“Of all the diseases or disabling conditions that are presently on the list in Connecticut, I find it hard or difficult to see how this would not be joining some of the other neuropathic conditions,” board member Jonathan Kost said. .
Certainly, Kost said, more studies are needed to further understand the effects of medical marijuana.